Hot topics close

Fewer treatment options? Multidrug resistance and the challenge of controlling Acinetobacter baumannii in Latvian hospitals

Fewer treatment options Multidrug resistance and the challenge of 
controlling Acinetobacter baumannii in Latvian hospitals
Acinetobacter baumannii is a bacterium that can cause a variety of infections associated with medical settings, as this is where infections are most commonly contracted. In 2022, Latvia still had one of the highest levels of resistance to Acinetobacter ba

Acinetobacter baumannii is a bacterium that can cause a variety of infections associated with medical settings, as this is where infections are most commonly contracted.

In 2022, Latvia still had one of the highest levels of resistance to Acinetobacter baumannii: 63.3% of Acinetobacter spp. samples were resistant to fluoroquinolones, aminoglycosides and carbapenems, which are antibiotics used to treat bacterial infections.

slimnica_shutterstock00.jpgPatient in hospital. Photo: Shutterstock

In his 2014 review of antimicrobial resistance, which occurs when bacteria, viruses or other micro-organisms become resistant to drugs, British economist Jim O'Neill predicted that unless strong action is taken, 10 million people worldwide could die each year from infections caused by resistant micro-organisms by 2050. This would exceed the current global death toll from cancer.

In the latest World Health Organisation report, the World Bank estimates that antimicrobial resistance could cost up to 3.8% of global GDP by 2050. Joint replacement, caesarean section, chemotherapy and various types of transplantation are among the treatments that depend on affordable and effective antimicrobials. Without them—and in the face of widespread antimicrobial resistance—many of these treatments could become riskier or even impossible.

Māris Liepiņš' doctoral thesis explores how long Acinetobacter baumannii remains in the body after infection. This information is crucial for determining the optimal timing for preventing and controlling the spread of the infection.

The results of the study provide a scientific basis for the development of strategies to improve infection control.

The defence of Māris Liepiņš's doctoral thesis, titled ‘Duration of carriage of multidrug-resistant Acinetobacter baumannii and its impact on infection control measures and antimicrobial use’, will take place on 12 November.

For more information, visit the event's page.

RSU dissertation catalogue

Similar news
News Archive
  • Information system
    Information system
    Geospatial Analytics Market to Hit USD 256 Billion by 2028, at a CAGR of 17.6% from 2022-2028 due to Its Key Role in Optimal Deployment of Networks
    2 Feb 2023
    15
  • Toyota Supra
    Toyota Supra
    Tom’s Racing Special Toyota GR Supra Pays Tribute To Paul Walker
    30 Sep 2021
    8
  • Gong Xi Fa Cai
    Gong Xi Fa Cai
    Gong Xi Fa Cai: Lucy and Wendyl master Chinese New Year ...
    7 Feb 2024
    3
  • Seed money
    Seed money
    Swedish startup secures €10M to turn waste into cement
    23 Sep 2024
    3
  • Bloodborne
    Bloodborne
    Bloodborne Remake Hopes Raised By New Leak
    10 Mar 2024
    3
  • Xdinary Heroes
    Xdinary Heroes
    Xdinary Heroes - JYP's first boy band in 6 years - debuts with 'Happy Death Day'
    6 Dec 2021
    1
This week's most popular news